Cubist Pharmaceuticals

Cubist Pharmaceuticals Incorporated is a drug company focused on the discovery, development and commercialization of novel drugs to treat infections. Daptomycin, the Company's in-licensed lead product, is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections. Cubist Pharmaceuticals began Phase III clinical trials of intravenous daptomycin for complicated skin and soft tissue infections and also began a Phase II clinical trial for bacteremia in February of 1999. Cubist is also applying its VITA-TM- technology to validate unique targets and to build assays to identify additional novel compounds with a broad spectrum of activity against life-threatening infectious organisms such as methicillin resistant STAPHYLOCOCCUS AUREUS (MRSA) and vancomycin resistant enterococci (VRE).

Contact Details: 65 Hayden Avenue Lexington MA 02421 United States of America Tel: (781) 860-8660 Fax: (781) 861-0566 Email: WWW: www.cubist.com/

Loading...

Recent Publications by Cubist Pharmaceuticals:
Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry. AIM: To compare and contrast the characteristics and clinical outcomes of...	19th August, 2008	Cubist Pharmaceuticals, Inc., Lexington, MA 02421, USA.	Int J Clin Pract. 2008 Aug;62(8):1183-7. DOI Direct Link
A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. Background: Methicillin-susceptible and -resistant (MRSA) Staphylococcus...	30th July, 2008	Cubist Pharmaceuticals, Inc., Lexington, MA, USA.	Int J Clin Pract. 2008 Jul 25. DOI Direct Link
Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia. OBJECTIVE: We sought to compare daptomycin with ceftriaxone for the...	29th July, 2008	Cubist Pharmaceuticals, Lexington, Massachusetts 02421, USA.	Clin Infect Dis. 2008 Apr 15;46(8):1142-51. DOI Direct Link
Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. The ability of daptomycin to produce bactericidal activity against...	17th July, 2008	Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, MA 02421, USA.	Antimicrob Agents Chemother. 2008 Jun;52(6):2223-5. Epub 2008 Mar 31. DOI Direct Link
Associations between the Genotype of Staphylococcus aureus Bloodstream Isolates and the Clinical Characteristics and Outcomes of Bacteremic Patients. We investigated associations between the genotypic and phenotypic features...	4th July, 2008	Division of Infectious Diseases, Duke University Medical Center, Durham,	J Clin Microbiol. 2008 Jul 2. DOI Direct Link
→View more Cubist Pharmaceuticals research publications.

BioNews Results for Cubist Pharmaceuticals:
Cubist Pharmaceuticals to Present at September Investor Conferences	SmartBrief:  Aug 30 2008 11:57AM Matching: cubist pharmaceuticals
Cubist Pharmaceuticals to Present at September Investor Conferences	Genetic Engineering News:  Aug 29 2008 4:01PM Matching: cubist pharmaceuticals
Cubist Pharmaceuticals to Present at September Investor Conferences	MarketWatch:  Aug 29 2008 3:20PM Matching: cubist pharmaceuticals
Cubist Pharmaceuticals to Present at September Investor Conferences	Genetic Engineering News:  Aug 29 2008 5:38PM Matching: cubist pharmaceuticals
Cubist Pharmaceuticals to Present at September Investor Conferences	Street Insider:  Aug 29 2008 3:59PM Matching: cubist pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Cubist Pharmaceuticals news.

Cubist Pharmaceuticals Patents:
US Patent No.	Title
7408025	Lipopeptides as antibacterial agents
6333344	Prolines as antimicrobial agents
6221640	Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
6174713	Candida cytoplasmic tryptophanyl-tRNA synthetase proteins, nucleic acids and strains comprising same
6153645	Heterocycles as antimicrobial agents
→View more Cubist Pharmaceuticals patents.

Cubist Pharmaceuticals (CBST) Financial information Links from Barchart
CBST Quote from from Barchart.com
CBST Chart from from Barchart.com
CBST Profile from from Barchart.com
CBST Opinion from from Barchart.com
→View more Cubist Pharmaceuticals finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 15 individuals from Cubist Pharmaceuticals using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 196 times since April 2007, the link to the organisation's website has been followed 27 times

Recent Search Terms used to find this page: cubist | cubist | Cubist Pharmaceuticals ltd | 1 Nat Prod Rep. 2007 Dec 24 6 1225-44. Epub 2007 May 9. Links | Cubist pHARMACEUTICALS | .

Search for more companies in Lexington

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cubist Pharmaceuticals